West Oak Capital, LLC Novartis Ag Transaction History

West Oak Capital, LLC

$5.38 Billion
Q3 2024

A detailed history of West Oak Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, West Oak Capital, LLC holds 18,653 shares of NVS stock, worth $1.81 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

18,653

Previous 18,348 1.66%

Holding current value

$1.81 Million

Previous $1.95 Million 998.57%

% of portfolio

0.4%

Previous 1.09%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$106.13 - $120.89 $32,369 - $36,871	305 Added 1.66%	18,653 $21.5 Million
Q2 2024 Jul 24, 2024	BUY	$92.57 - $107.37 $475,809 - $551,881	5,140 Added 38.92%	18,348 $1.95 Million
Q1 2024 Apr 18, 2024	BUY	$95.27 - $108.47 $23,817 - $27,117	250 Added 1.93%	13,208 $1.28 Million
Q4 2023 Jan 17, 2024	BUY	$92.27 - $101.54 $32,294 - $35,539	350 Added 2.78%	12,958 $1.39 Million
Q1 2023 Apr 21, 2023	SELL	$80.03 - $92.81 $45,216 - $52,437	-565 Reduced 4.29%	12,608 $1.16 Million
Q4 2022 Jan 05, 2023	SELL	$75.55 - $92.52 $51,751 - $63,376	-685 Reduced 4.94%	13,173 $1.2 Million
Q2 2022 Jul 11, 2022	SELL	$80.52 - $93.75 $26,330 - $30,656	-327 Reduced 2.31%	13,858 $1.17 Million
Q1 2022 Apr 20, 2022	BUY	$80.11 - $90.62 $78,908 - $89,260	985 Added 7.46%	14,185 $1.25 Million
Q4 2021 Jan 12, 2022	SELL	$79.7 - $88.13 $114,768 - $126,907	-1,440 Reduced 9.84%	13,200 $1.16 Million
Q3 2021 Oct 07, 2021	SELL	$81.78 - $95.14 $11,040 - $12,843	-135 Reduced 0.91%	14,640 $1.2 Million
Q2 2021 Jul 20, 2021	SELL	$85.24 - $94.15 $199,461 - $220,311	-2,340 Reduced 13.67%	14,775 $1.35 Million
Q1 2021 Apr 13, 2021	BUY	$83.5 - $98.47 $10,020 - $11,816	120 Added 0.71%	17,115 $1.46 Million
Q4 2020 Jan 08, 2021	BUY	$78.07 - $94.43 $21,859 - $26,440	280 Added 1.68%	16,995 $1.61 Million
Q3 2020 Oct 09, 2020	SELL	$82.14 - $91.0 $27,106 - $30,030	-330 Reduced 1.94%	16,715 $1.45 Million
Q2 2020 Jul 06, 2020	BUY	$80.93 - $91.1 $9,711 - $10,932	120 Added 0.71%	17,045 $1.49 Million
Q1 2020 Apr 07, 2020	SELL	$70.67 - $99.01 $1,060 - $1,485	-15 Reduced 0.09%	16,925 $1.4 Million
Q4 2019 Jan 09, 2020	SELL	$84.35 - $95.37 $64,527 - $72,958	-765 Reduced 4.32%	16,940 $1.6 Million
Q3 2019 Oct 02, 2019	BUY	$85.54 - $94.26 $38,493 - $42,417	450 Added 2.61%	17,705 $1.54 Million
Q2 2019 Jul 12, 2019	BUY	$75.4 - $92.8 $52,026 - $64,032	690 Added 4.17%	17,255 $1.58 Million
Q1 2019 Apr 03, 2019	SELL	$75.32 - $86.15 $3,012 - $3,446	-40 Reduced 0.24%	16,565 $1.59 Million
Q3 2018 Oct 04, 2018	BUY	$66.94 - $77.43 $21,755 - $25,164	325 Added 2.0%	16,605 $1.43 Billion
Q2 2018 Jul 06, 2018	BUY	$64.91 - $73.36 $24,016 - $27,143	370 Added 2.33%	16,280 $1.23 Billion
Q1 2018 Apr 05, 2018	BUY	$70.39 - $84.15 $3,519 - $4,207	50 Added 0.32%	15,910 $1.29 Billion
Q4 2017 Jan 05, 2018	BUY	$72.33 - $77.64 $48,099 - $51,630	665 Added 4.38%	15,860 $1.33 Billion
Q3 2017 Oct 10, 2017	BUY	$74.14 - $77.27 $1.13 Million - $1.17 Million	15,195	15,195 $1.3 Billion

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Oak Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Oak Capital, LLC with notifications on news.

Account

West Oak Capital, LLC Novartis Ag Transaction History